See the DrugPatentWatch profile for cosentyx

Based on the information available, there do not appear to be weight-based restrictions for the use of Cosentyx (secukinumab) [1]. Cosentyx is a biologic medication used to treat a variety of conditions, including psoriasis, psoriatic arthritis, and ankylosing spondylitis [1].

The prescribing information for Cosentyx, which is approved by the US Food and Drug Administration (FDA), does not list weight as a factor in determining the appropriate dosage for the medication [2]. Instead, the dosage is typically determined based on the patient's body weight and the specific condition being treated [2].

It is important to note that, like all medications, Cosentyx can have side effects and may not be appropriate for all patients [1]. Patients should speak with their healthcare provider to determine if Cosentyx is right for them, and to discuss any potential risks and benefits [1].

In summary, based on the available information, there do not appear to be weight-based restrictions for the use of Cosentyx. However, patients should speak with their healthcare provider to determine the appropriate dosage and to discuss any potential risks and benefits.

Sources:

1. Cosentyx (secukinumab) [prescribing information]. Novartis Pharmaceuticals Corporation; 2021. Available at: <https://www.novartis.us/sites/www.novartis.us/files/cosentyx.pdf>.
2. DrugPatentWatch.com. Cosentyx (secukinumab) [patent information]. Available at: <https://www.drugpatentwatch.com/drugs/cosentyx>.